Understanding puritus in systemic disease

Journal of Pain and Symptom Management

Volumn 21, Issue 2, 2001, Pages 151-168

  Krajnik, Małgorzata ^a   Zylicz, Zbigniew ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Hospice Rozenheuvel   (Netherlands)

Author keywords

Central transmitters; Histamine; Itch; Pruritus; Serotonin; Systemic disorders

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIPRURITIC AGENT; CAPSAICIN; COLESTYRAMINE; CYPROHEPTADINE; DOXEPIN; ENDORPHIN; HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE RECEPTOR; HYDROXYZINE; LEUKOTRIENE B4; MORPHINE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE; OPIATE ANTAGONIST; PAROXETINE; PIMOZIDE; SEROTONIN; SEROTONIN ANTAGONIST; SUBSTANCE P;

BLOOD DISEASE; ENDOCRINE DISEASE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAST CELL; PAIN; PATHOGENESIS; PRURITUS; REVIEW; SCRATCHING; SENSATION; SYSTEMIC DISEASE; ULTRAVIOLET RADIATION; HUMAN; NERVOUS SYSTEM; PALLIATIVE THERAPY; PATHOPHYSIOLOGY;

HUMANS; NERVOUS SYSTEM; PAIN; PALLIATIVE CARE; PRURITUS;

EID: 0034746255     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00256-6     Document Type: Review

References (142)

1. Itch and pain
2. Pruritus-itching for a cause and relief?
3. Itch and atopic dermatitis; Clinical and experimental studies
4. Poststroke pruritus
5. Sensory responses of human skin to synthetic histamine analogues and histamine
6. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
7. The intradermal effects of the H3 receptor agonist R alpha methylhistamine in human skin
8. Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex
9. Histamine-caused itch induces Fos-like immunoreactivity in dorsal horn neurons; Effect of morphine pretreatment
10. Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms
11. Pruritus
12. Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch?
13. Pruritus in polycythemia vera; Treatment with aspirin and possibility of platelet involvement
14. Pruritus of polycythaemia vera; A place for pizotifen?
15. Whole blood serotonin levels are markedly elevated in patients on dialytic therapy
16. Naloxone modulates the perception of itch in man
17. The antipruritic effect of a 5-HT3 receptor antagonist (tropisetron) is dependent on mast cell depletion-an experimental study
18. Itching for an explanation
19. Conditioning of histamine by bradykinin alters responses of rat nociceptor and human itch sensation
20. The gate control theory of pain mechanisms. A re-examination and re- statement
21. Does uremic pruritus in hemodialyzed patients disappear only with replacement therapy?
22. Scratch radar for the measurement of pruritus
23. Improved device for measuring scratching activity in patients with pruritus
24. Pruritus
25. Generalized pruritus and systemic disease
26. Uremic pruritus
27. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia
28. The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients
29. Effects of azelastin on pruritus and plasma histamine levels in hemodialysis patients
30. Thalidomide for the treatment of uremic pruritus; A crossover randomized double-blind trial
31. Topical capsaicin for treatment of hemodialysis-related pruritus
32. Oral activated charcoal in patients with uremic pruritus
33. Cholestyramine in uraemic pruritus
34. UV treatment of uraemic pruritus reduces the vitamin A content of the skin
35. Identifying effective treatments for uremic pruritus
36. Randomised crossover trial of naltrexone in uraemic pruritus
37. Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres; Evidence for sprouting in uremic patients on maintenance hemodialysis
38. Postoperative ulnar neuropathy after kidney transplantation
39. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy
40. Uremic pruritus; Roles of parathyroid hormone and substance P
41. Uraemic pruritus
42. Disappearance of uraemic pruritus after lowering dialysate magnesium concentration
43. Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin; Plasma levels of substance P, somatostatin, IgE, PTH and histamine
44. Dialysis pruritus; Effect of cimetidine
45. Pruritus as a manifestation of systemic disorders
46. The 'butterfly' sign. A clue to generalized pruritus in a patient with chronic obstructive hepatobiliary disease
47. Elevations in skin tissue levels of bile acids in human cholestasis; Relation to serum levels and topruritus
48. The pruritus of cholestasis
49. Oral naltrexone treatment for cholestatic pruritus; A double-blind, placebo-controlled study
50. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis; A controlled study
51. Buprenorphine and hepatic pruritus
52. Codeine for pruritus in primary billiary cirrhosis
53. Relief of cholestatic pruritus by a novel class of drugs; 5- hydroxytryptamine type 3 (5-HT3) receptor antagonists: Effectiveness of ondansetron
54. Opioid antagonists in the treatment of pruritus from cholestatic liver disease
55. Subhypnotic doses of propofol relieve pruritus associated with liver disease
56. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial
57. Rifampicin as treatment for pruritus in malignant cholestasis
58. A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis
59. Cimetidine treatment of pruritus in polycythemia vera
60. Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera
61. A study of histamine in myeloproliferative disease
62. Relief of intractable pruritis in polycythaemia rubra vera with cholestyramine
63. Should the patient with generalized pruritus be evaluated for malignancy?
64. Severe pruritus should be a B-symptom in Hodgkin's disease
65. Itch and malignancy prognosis in generalized pruritus; A 6-year follow-up of 125 patients
66. Pruritus as a presentation of myelomatosis
67. Pruritus; Pathogenesis, therapy, and significance in systemic disease states
68. Pruritic specific cutaneous infiltrates in leukemia and lymphoma
69. Treatment of therapy-resistant Sezary syndrome with Cyclosporin-A; Suppression of pruritus, leukaemic T cell activation markers and tumour mass
70. Cimetidine for pruritus in Hodgkin's disease
71. Iron-deficiency pruritus
72. Cutaneous manifestations of hyperthyroidism
73. Association of chronic urticaria and angioedema with thyroid autoimmunity
74. Cutaneous signs of diabetes mellitus
75. Pruritus in diabetes mellitus; Investigation of prevalence and correlation with diabetes control
76. Pruritus, an uncommon but important symptom of systemic carcinoma
77. Skin manifestations associated with tumours of the brain
78. Endogenous allergy
79. Decreased skin response to intradermal histamine in cancer patients
80. Itching after epidural and spinal opiates
81. Intrathecal diamorphine for analgesia after caesarean section. A dose finding study and assessment of side-effects
82. Epidural morphine for analgesia after caesarean section; A report of 4880 patients
83. Eyelid pruritus with intravenous morphine
84. The medullary dorsal horn. A site of action of morphine in producing facial scratching in monkeys
85. Intracisternal injection of opioids induces itch-associated response through mu-opioid receptors in mice
86. Intraspinal opiates and itching; a new reflex?
87. Serotonin and nociception
88. Ondansetron is effective to treat spinal or epidural morphine-induced pruritus
89. The use of ondansetron to treat pruritus associated with intrathecal morphine in two paediatric patients
90. Nalbuphine is better than naloxone for treatment of side effects after epidural morphine
91. Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines
92. Butorphanol-induced pruritus antagonized by naloxone
93. Multiple effects of morphine on facial scratching in monkeys
94. Mechanism of action of antipruritic drugs
95. Histamine release during morphine and fentanyl anesthesia
96. Behavioral and histopathologic effects following intrathecal administration of butorphanol, sufentanil, and nalbuphine in sheep
97. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone
98. Opioid-induced itching; Morphine sulfate and hydromorphone hydrochloride
99. The effect of rectal diclofenac on pruritus in patients receiving intrathecal morphine
100. Paroxysmal itching in multiple sclerosis
101. Unilateral neurogenic pruritus following stroke
102. Unilateral pruritus and Nocardia brain abscess
103. Notalgia paraesthetica-report of three cases and their treatment
104. Der paresthetische Neuralgien und einde bezondere Form derselben-Nothalgia paresthetica
105. Treatment of notalgia paresthetica with topical capsaicin
106. Post-herpetic pruritus
107. Increased cutaneous fibrinolytic activity in aquagenic pruritus
108. Treatment of aquagenic pruritus with topical capsaicin cream
109. The efficacy of psoralen photochemotherapy in the treatment of aquagenic pruritus
110. Pruritus secondary to hydroxyurea therapy in a woman with polycythemia vera
111. Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin
112. Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis
113. Treatment of PUVA itch with capsaicin
114. Pruritus as a presenting sign of acquired immunodeficiency syndrome
115. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus
116. Pruritic papular eruption in HIV seropositive patients; A cutaneous marker for immunosuppression
117. Clinical significance of eosinophilia in HIV-infected individuals
118. Distinct serum cytokines in AIDS-related skin diseases
119. Intractable pruritus in HIV infection; immunologic characterization
120. Outbreak of itching and rash. Epidemic hysteria in an elementary school
121. Hypnosis in a case of long-standing idiopathic itch
122. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis
123. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria
124. Paroxetine for pruritus in advanced cancer
125. Histamine and serotonin in uremic pruritus; Effect of ondansetron in CAPD-pruritic patients
126. Management of opioid-induced pruritus; A role for 5-HT3 antagonists?
127. Relief of uremic pruritus with ultraviolet phototherapy
128. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases
129. Itching-research has barely scratched the surface
130. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron; A randomized, placebo-controlled, double-blind cross-over trial
131. Activated charcoal rediscovered
132. Uremic pruritus; an unresolved problem in hemodialysis patients